Filter
6588
Filtered Results: 6588
Text search:
Global
health
and
environment
Featured
Recommendations
544
New Publications
1668
Language
Document type
No document type
3438
Studies & Reports
1410
Guidelines
745
Manuals
343
Strategic & Response Plan
318
Fact sheets
123
Training Material
98
Situation Updates
44
Resource Platforms
32
Infographics
19
Online Courses
8
Brochures
6
Videos
2
Dashboards/Maps
1
App
1
Countries / Regions
Global
365
India
195
Kenya
193
Ethiopia
132
Uganda
126
South Africa
123
Nigeria
117
Western and Central Europe
115
Myanmar / Burma
112
Sierra Leone
110
Africa
108
Liberia
107
Nepal
106
Latin America and the Carribbean
104
Malawi
98
Zambia
92
Bangladesh
92
Syria
88
Rwanda
86
Ghana
77
Tanzania
76
Congo, Democratic Republic of
63
Ukraine
63
South Sudan
54
South–East Asia Region
54
Namibia
53
Philippines
52
Indonesia
45
Asia
45
Eastern Europe
44
Zimbabwe
43
Lesotho
40
Senegal
39
Yemen
37
Cambodia
35
West and Central Africa
35
Haiti
34
Mozambique
33
Russia
33
Guinea
31
Middle East and North Africa
30
East and Southern Africa
29
Afghanistan
27
Brazil
27
Pakistan
26
Burkina Faso
23
Cameroon
23
Botswana
22
Sudan
21
Venezuela
20
Jordan
19
Lebanon
18
Colombia
18
Somalia
17
Western Pacific Region
17
Germany
16
Thailand
16
Central African Republic
16
Eswatini/ Swaziland
16
Vietnam
16
Eastern Europe and Central Asia
15
Mali
13
Chile
11
Tajikistan
11
Laos
10
Iraq
9
China
9
Peru
9
USA
8
Turkey
8
Ecuador
8
Albania
8
Georgia
8
Chad
7
Benin
7
Sri Lanka
7
Moldova
7
North America
7
Côte d’Ivoire / Ivory Coast
6
North Macedonia
6
Madagascar
6
Southern Africa
6
Iran
6
Spain
6
Niger
5
Argentina
5
Mexico
5
Paraguay
5
Palestine
5
Kyrgyzstan
5
Turkmenistan
5
Jamaica
5
Portugal
5
Saudi Arabia
4
Honduras
4
Kazakhstan
4
Japan
4
Egypt
3
Gambia
3
Papua New Guinea
3
Croatia
3
Burundi
3
Bolivia
3
Libya
3
Angola
3
Djibouti
3
United Kingdom
3
Belarus
3
Bosnia and Herzegovina
3
Guinea-Bissau
2
Morocco
2
Togo
2
Malaysia
2
Mauritania
2
Dominican Republic
2
Hungary
2
El Salvador
2
Guatemala
2
Other region
2
Fiji
2
Bhutan
2
Italy
2
Armenia
2
Timor Leste/ East Timor
2
Qatar
2
Romania
2
Lithuania
2
Mauritius
2
Azerbaijan
2
Israel
2
Ireland
1
Serbia
1
Cuba
1
Greece
1
Nicaragua
1
Poland
1
Canada
1
Bulgaria
1
Uzbekistan
1
Gabon
1
Denmark
1
France
1
Maldives
1
Tunisia
1
Norway
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
2260
Public Health
443
Key Resources
391
Clinical Guidelines
388
Women & Child Health
346
Capacity Building
129
Pharmacy & Technologies
61
Annual Report MEDBOX
2
Toolboxes
COVID-19
514
Planetary Health
502
HIV
431
Mental Health
431
Disability
318
TB
267
AMR
260
Conflict
203
Global Health Education
199
Rapid Response
194
Caregiver
189
NTDs
167
NCDs
153
Ebola
129
Refugee
118
Natural Hazards
107
Pharmacy
89
Health Financing Toolbox
59
Polio
54
Cholera
48
Zika
39
Social Ethics
36
Specific Hazards
35
Typhoon
3
Health Financing
2
South Sudan
1
These guidelines provide a recommendation on iodine thyroid blocking (ITB), via oral administration of stable iodine, as an urgent protective action in responding to a nuclear accident. This recommendation aims to support emergency planners, policy makers, public ... specialists, clinicians and other relevant stakeholders, in order to strengthen public health preparedness for radiation emergencies in WHO Member States as required by the International Health Regulations (IHR) and in line with the international safety standards (GSR Part 7). The scope of the guidelines is confined to public health aspects of planning and implementation of ITB before and during a radiation emergency, such as dosage and timing of ITB administration, adverse effects of stable iodine, its packaging, storage, and distribution.
These guidelines supersede the 1999 WHO Guidelines for Iodine Prophylaxis following Nuclear Accidents.
Policy Guidance Brief 1
• Climate change has already challenged the agriculture sector in Myanmar by afecting rice yields and livestock production, while disasters such as foods and cyclones...
• Climate change has already challenged the agriculture sector in Myanmar by afecting rice yields and livestock production, while disasters such as foods and cyclones...
Health Evidence Network synthesis report 72
The Joint Monitoring Programme (JMP) report – Progress on household drinking water, sanitation and hygiene 2000 - 2020 – presents estimates on household access to safely managed drinking water, sanitation ... hygiene services over the past five years, and assesses progress toward achieving the sixth sustainable development goal (SDG) to ‘Ensure availability and sustainable management of water and sanitation for all by 2030’.
This document aims to provide interim guidance for microbiology and virology experts, other laboratory professionals, laboratory managers, infectious disease programme managers, public health profes...
This report’s central premise is that diagnostics and therapeutics, and associated test to treat strategies, are fundamental components of the pandemic response, both for COVID-19 ... for future health threats. Two years into the COVID-19 pandemic, this report reflects on the main challenges and key solutions on the road to equitable access to diagnostics and therapeutics.
This report draws from experience gained through the Access to COVID-19 Tools (ACT) Accelerator Diagnostics and Therapeutics pillars, and includes the perspectives of collaborating stakeholders (countries, civil society representatives and the private sector). Building on these findings, this report proposes sixteen recommended actions to address what have been identified as key structural challenges and specifies a potential owner for each action.
Background: Cardiovascular disease (CVD), mainly heart attack and stroke, is the
leading cause of premature mortality in low and middle income countries (LMICs).
Identifying ... managing individuals at high risk of CVD is an important strategy to prevent and control CVD, in addition to multisectoral population-based interventions to reduce CVD risk factors in the entire population.
Methods: We describe key public health considerations in identifying and managing individuals at high risk of CVD in LMICs.
Results: A main objective of any strategy to identify individuals at high CVD risk is to maximize the number of CVD events averted while minimizing the numbers of
individuals needing treatment. Scores estimating the total risk of CVD (e.g. ten-year risk of fatal and non-fatal CVD) are available for LMICs, and are based on the main CVD risk factors (history of CVD, age, sex, tobacco use, blood pressure, blood cholesterol and diabetes status). Opportunistic screening of CVD risk factors enables identification of persons with high CVD risk, but this strategy can be widely applied in low resource settings only if cost effective interventions are used (e.g. the WHO Package of Essential NCD interventions for primary health care in low resource settings package) and if treatment (generally for years) can be sustained, including continued availability ofaffordable medications and funding mechanisms that allow people to purchase medications without impoverishing them (e.g. universal access to health care). Thisalso emphasises the need to re-orient health systems in LMICs towards chronic diseases management.
Conclusion: The large burden of CVD in LMICs and the fact that persons with high
CVD can be identified and managed along cost-effective interventions mean that
health systems need to be structured in a way that encourages patient registration, opportunistic screening of CVD risk factors, efficient procedures for the management of chronic conditions (e.g. task sharing) and provision of affordable treatment for those with high CVD risk. The focus needs to be in primary care because that is where most of the population can access health care and because CVD programmes can be run effectively at this level.
Hepatitis B (HBV) infection is a major public health problem and cause of chronic liver disease.
The 2024 HBV guidelines provide updated evidence-informed recommendations on key priority topics. ...
The Resolution Population and Individual Approaches to the Prevention and Management of Diabetes and Obesity was approved by the 48th Directing Cou...
The objectives of these WHO guidelines are to provide updated evidence- based recommendations for the treatment of persons with hepatitis C infection using, where possible, all DAA-only combinations. The guidelines also provide recommendations on the preferred regimens based on a patient’s HCV gen...
Further analysis of the 2011 Nepal Demographic and Health Survey
Report of the 23rd WHO Expert Committee on the selection and use of essential medicines
This executive summary reports the recommendations made by the Expert Committee for the 2021 update of the WHO Model List of Essential Medicines (EML) ... the Model List of Essential Medicine for Children (EMLc).
The 23rd meeting of the WHO Expert Committee on Selection and Use of Essential Medicines was coordinated from Geneva, Switzerland, and held virtually from 21 June to 2 July 2021. The Committee considered 88 applications proposing additions, changes and deletions of medicines, medicine classes and formulation on the Model Lists of Essential Medicines. The Committee evaluated the scientific evidence for comparative effectiveness, safety and cost-effectiveness of the medicines in question. The Committee also considered a review of the therapeutic alternatives for medicines on the Model Lists, and update to the AWaRe classification of antibiotics, and reviews and reports relevant to the selection and use of essential medicines.
The ICOPE Implementation Framework provides a score card to help assess the overall capacity of health and social care services and systems to deli...
11 august 2022, updated version
Mohamed et al. BMC Public Health 2018, 18(Suppl 3):1215
https://doi.org/10.1186/s12889-018-6053-xpre-
These policy guidelines provide a strategic approach and new recommendations for integrated TB and HIV services for patients suffering from substance-abuse addiction. The key recommendations fall un...
